The story of Viagra, and its effect on the pharmaceutical landscape, presents a nuanced case for investors . Initially a phenomenal success, producing billions in income , the intellectual property expiration has opened the possibility for generic versions, substantially eroding market volume. While established pharmaceutical firms involved may … Read More